COSMO Pharmaceuticals SA (COPN) — Long-term Investment Intensity
COSMO Pharmaceuticals SA (COPN) has a Long-term Investment Intensity of 24.3% as of June 2019. Long-term investments of CHF144.35 Million represent 24.3% of total assets of CHF594.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check COPN financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
COSMO Pharmaceuticals SA Long-term Investment Intensity (2013–2018)
This chart shows how COSMO Pharmaceuticals SA's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 24.3%, reflecting long-term investments of CHF144.35 Million against total assets of CHF594.73 Million CHF. For the complete balance sheet picture, see COPN total asset value.
Annual Long-term Investment Intensity for COSMO Pharmaceuticals SA (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for COSMO Pharmaceuticals SA from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read COPN total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 27.5% | CHF172.26 Million | CHF625.69 Million | ▼ -18.6 pp |
| 2017 | 46.1% | CHF229.55 Million | CHF497.97 Million | ▼ -2.0 pp |
| 2016 | 48.1% | CHF213.50 Million | CHF443.47 Million | ▼ -14.0 pp |
| 2015 | 62.2% | CHF272.22 Million | CHF437.94 Million | ▲ +8.6 pp |
| 2014 | 53.6% | CHF120.83 Million | CHF225.62 Million | ▲ +47.0 pp |
| 2013 | 6.6% | CHF16.00 Million | CHF243.00 Million | — |